iCAD Inc  

(Public, NASDAQ:ICAD)   Watch this stock  
Find more results for ICAD
3.68
-0.01 (-0.27%)
Jul 6 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.50 - 3.75
52 week 3.22 - 11.63
Open 3.65
Vol / Avg. 258,266.00/211,914.00
Mkt cap 57.82M
P/E     -
Div/yield     -
EPS -0.18
Shares 15.67M
Beta 1.80
Inst. own 48%
Jul 28, 2015
Q2 2015 ICAD Inc Earnings Release (Estimated) Add to calendar
Apr 30, 2015
Q1 2015 iCAD Inc Earnings Call
Apr 30, 2015
Q1 2015 iCAD Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -14.05% -2.30%
Operating margin -9.68% -0.20%
EBITD margin - 9.88%
Return on average assets -8.46% -1.32%
Return on average equity -11.98% -2.40%
Employees 144 -
CDP Score - -

Address

98 Spit Brook Rd Ste 100
NASHUA, NH 03062-5737
United States - Map
+1-603-8825200 (Phone)
+1-603-8803843 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

iCAD, Inc. is a provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The Company provides image analysis and clinical decision support solutions for mammography, Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) imaging. The Company operates in two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). The Detection segment consists of the Company's advanced image analysis and workflow products, and the Therapy segment consists of its radiation therapy products. The Company sells its products throughout the world through its direct sales organization, as well as through various original equipment manufacturer (OEM) partners, distributors and resellers.

Officers and directors

Lawrence Howard Chairman of the Board
Age: 62
Bio & Compensation  - Reuters
Kevin C. Burns President, Chief Financial Officer, Chief Operating Officer
Age: 44
Bio & Compensation  - Reuters
Kenneth M. Ferry Chief Executive Officer, Director
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Stacey M. Stevens Senior Vice President - Marketing and Strategy
Age: 47
Bio & Compensation  - Reuters
Jonathan Go Senior Vice President - Research and Development
Age: 52
Bio & Compensation  - Reuters
Rachel Brem M.D. Independent Director
Age: 56
Bio & Compensation  - Reuters
Anthony F. Ecock Independent Director
Age: 53
Bio & Compensation  - Reuters
Robert L. Goodman M.D. Independent Director
Age: 74
Bio & Compensation  - Reuters
Steven N. Rappaport Independent Director
Age: 66
Bio & Compensation  - Reuters
Somu Subramaniam Independent Director
Age: 60
Bio & Compensation  - Reuters